Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Royal London Asset Management Ltd.

Royal London Asset Management Ltd. grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 0.8% in the 4th quarter, HoldingsChannel.com reports. The fund owned 486,243 shares of the medical equipment provider’s stock after purchasing an additional 4,072 shares during the quarter. Royal London Asset Management Ltd.’s holdings in Intuitive Surgical were worth $164,039,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently modified their holdings of ISRG. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA lifted its holdings in shares of Intuitive Surgical by 0.3% during the fourth quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 8,899 shares of the medical equipment provider’s stock worth $3,002,000 after buying an additional 27 shares during the last quarter. Sheaff Brock Investment Advisors LLC lifted its holdings in shares of Intuitive Surgical by 1.3% during the fourth quarter. Sheaff Brock Investment Advisors LLC now owns 2,226 shares of the medical equipment provider’s stock worth $751,000 after buying an additional 29 shares during the last quarter. Liberty Capital Management Inc. lifted its holdings in shares of Intuitive Surgical by 3.8% during the fourth quarter. Liberty Capital Management Inc. now owns 815 shares of the medical equipment provider’s stock worth $275,000 after buying an additional 30 shares during the last quarter. Miracle Mile Advisors LLC lifted its holdings in shares of Intuitive Surgical by 2.3% during the fourth quarter. Miracle Mile Advisors LLC now owns 1,438 shares of the medical equipment provider’s stock worth $485,000 after buying an additional 32 shares during the last quarter. Finally, Ausdal Financial Partners Inc. lifted its holdings in shares of Intuitive Surgical by 1.5% during the fourth quarter. Ausdal Financial Partners Inc. now owns 2,192 shares of the medical equipment provider’s stock worth $739,000 after buying an additional 33 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on ISRG. Jefferies Financial Group upped their target price on Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a research note on Friday, April 19th. Stifel Nicolaus upped their target price on Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, April 8th. Piper Sandler upped their target price on Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a research note on Friday, April 19th. The Goldman Sachs Group began coverage on Intuitive Surgical in a research note on Thursday, May 30th. They issued a “buy” rating and a $500.00 target price for the company. Finally, BTIG Research upped their target price on Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a research note on Friday, April 19th. Five analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $403.67.

Read Our Latest Analysis on ISRG

Insider Transactions at Intuitive Surgical

In related news, Director Alan J. Levy sold 2,000 shares of the firm’s stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total value of $741,400.00. Following the transaction, the director now owns 25,319 shares in the company, valued at $9,385,753.30. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, EVP Myriam Curet sold 5,318 shares of the firm’s stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $370.66, for a total value of $1,971,169.88. Following the transaction, the executive vice president now owns 298 shares in the company, valued at $110,456.68. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Alan J. Levy sold 2,000 shares of the firm’s stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $370.70, for a total value of $741,400.00. Following the completion of the transaction, the director now owns 25,319 shares in the company, valued at approximately $9,385,753.30. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 17,956 shares of company stock worth $6,927,011. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG stock traded up $2.88 during trading hours on Friday, hitting $425.78. 940,996 shares of the company’s stock were exchanged, compared to its average volume of 1,163,301. The stock’s 50-day moving average is $392.70 and its 200-day moving average is $374.43. The stock has a market cap of $151.02 billion, a price-to-earnings ratio of 76.86, a price-to-earnings-growth ratio of 5.50 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $428.86.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last announced its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, topping the consensus estimate of $1.40 by $0.10. The company had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The business’s revenue for the quarter was up 11.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.00 earnings per share. Equities research analysts forecast that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current fiscal year.

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Stories

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.